Lang Wu1, Zhen Wang2, Jingjing Zhu2, Angela L Murad2, Larry J Prokop2, Mohammad H Murad2. 1. L. Wu is with the Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, USA. Z. Wang is with the Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota, USA. Z. Wang and M.H. Murad are with the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. J. Zhu is with the Program of Quantitative Methods in Education, University of Minnesota, Minneapolis, Minnesota, USA. A.L. Murad is with the Dan Abraham Healthy Living Center, Mayo Clinic, Rochester, Minnesota, USA. L.J. Prokop is with the Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota. M.H. Murad is with the Division of Preventive Medicine, Mayo Clinic, Rochester, Minnesota, USA. Wu.Lang@mayo.edu. 2. L. Wu is with the Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, USA. Z. Wang is with the Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota, USA. Z. Wang and M.H. Murad are with the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. J. Zhu is with the Program of Quantitative Methods in Education, University of Minnesota, Minneapolis, Minnesota, USA. A.L. Murad is with the Dan Abraham Healthy Living Center, Mayo Clinic, Rochester, Minnesota, USA. L.J. Prokop is with the Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota. M.H. Murad is with the Division of Preventive Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
CONTEXT: The identification of foods that can decrease the risk of cancer and type 2 diabetes may be helpful in reducing the burden of these diseases. Although nut consumption has been suggested to have a disease-preventive role, current evidence remains inconsistent. OBJECTIVE: The aim of this systematic review and meta-analysis was to clarify the association between nut consumption and risk of cancer or type 2 diabetes. DATA SOURCES: Six databases were searched for relevant studies from the time of database inception to August 2014. Reference lists of relevant review articles were hand searched, and authors were contacted when data were insufficient. STUDY SELECTION: Eligible studies included epidemiological studies (case-control and cohort) or clinical trials that reported an association between nut consumption and the outcome of type 2 diabetes or specific cancers. DATA EXTRACTION: Two investigators independently extracted descriptive, quality, and risk data from included studies. DATA SYNTHESIS: Random-effects meta-analysis was used to pool relative risks from the included studies. The I(2) statistic was used to assess heterogeneity. A total of 36 eligible observational studies, which included 30,708 patients, were identified. The studies had fair methodological quality, and length of follow-up ranged between 4.6 years and 30 years. Comparison of the highest category of nut consumption with the lowest category revealed significant associations between nut consumption and decreased risk of colorectal cancer (3 studies each with separate estimates for males and females, RR 0.76, 95% confidence interval [95%CI] 0.61-0.96), endometrial cancer (2 studies, RR 0.58, 95%CI 0.43-0.79), and pancreatic cancer (1 study, RR 0.68, 95%CI 0.48-0.96). No significant association was found with other cancers or type 2 diabetes. Overall, nut consumption was significantly associated with a reduced risk of cancer incidence (RR 0.85, 95%CI 0.76-0.95). CONCLUSIONS: Nut consumption may play a role in reducing cancer risk. Additional studies are needed to more accurately assess the relationship between nut consumption and the prevention of individual types of cancer, given the scarcity of available data.
CONTEXT: The identification of foods that can decrease the risk of cancer and type 2 diabetes may be helpful in reducing the burden of these diseases. Although nut consumption has been suggested to have a disease-preventive role, current evidence remains inconsistent. OBJECTIVE: The aim of this systematic review and meta-analysis was to clarify the association between nut consumption and risk of cancer or type 2 diabetes. DATA SOURCES: Six databases were searched for relevant studies from the time of database inception to August 2014. Reference lists of relevant review articles were hand searched, and authors were contacted when data were insufficient. STUDY SELECTION: Eligible studies included epidemiological studies (case-control and cohort) or clinical trials that reported an association between nut consumption and the outcome of type 2 diabetes or specific cancers. DATA EXTRACTION: Two investigators independently extracted descriptive, quality, and risk data from included studies. DATA SYNTHESIS: Random-effects meta-analysis was used to pool relative risks from the included studies. The I(2) statistic was used to assess heterogeneity. A total of 36 eligible observational studies, which included 30,708 patients, were identified. The studies had fair methodological quality, and length of follow-up ranged between 4.6 years and 30 years. Comparison of the highest category of nut consumption with the lowest category revealed significant associations between nut consumption and decreased risk of colorectal cancer (3 studies each with separate estimates for males and females, RR 0.76, 95% confidence interval [95%CI] 0.61-0.96), endometrial cancer (2 studies, RR 0.58, 95%CI 0.43-0.79), and pancreatic cancer (1 study, RR 0.68, 95%CI 0.48-0.96). No significant association was found with other cancers or type 2 diabetes. Overall, nut consumption was significantly associated with a reduced risk of cancer incidence (RR 0.85, 95%CI 0.76-0.95). CONCLUSIONS:Nut consumption may play a role in reducing cancer risk. Additional studies are needed to more accurately assess the relationship between nut consumption and the prevention of individual types of cancer, given the scarcity of available data.
Authors: Sheila A Bingham; Nicholas E Day; Robert Luben; Pietro Ferrari; Nadia Slimani; Teresa Norat; Françoise Clavel-Chapelon; Emmanuelle Kesse; Alexandra Nieters; Heiner Boeing; Anne Tjønneland; Kim Overvad; Carmen Martinez; Miren Dorronsoro; Carlos A Gonzalez; Timothy J Key; Antonia Trichopoulou; Androniki Naska; Paolo Vineis; Rosario Tumino; Vittorio Krogh; H Bas Bueno-de-Mesquita; Petra H M Peeters; Göran Berglund; Göran Hallmans; Eiliv Lund; Guri Skeie; Rudolf Kaaks; Elio Riboli Journal: Lancet Date: 2003-05-03 Impact factor: 79.321
Authors: G G Giles; J J McNeil; G Donnan; C Webley; M P Staples; P D Ireland; S F Hurley; M Salzberg Journal: Int J Cancer Date: 1994-11-01 Impact factor: 7.396
Authors: Carrie A Thompson; Thomas M Habermann; Alice H Wang; Robert A Vierkant; Aaron R Folsom; Julie A Ross; James R Cerhan Journal: Int J Cancer Date: 2010-02-15 Impact factor: 7.396
Authors: Marta Guasch-Ferré; Geng Zong; Walter C Willett; Peter L Zock; Anne J Wanders; Frank B Hu; Qi Sun Journal: Circ Res Date: 2019-04-12 Impact factor: 17.367
Authors: Maryam Hashemian; Gwen Murphy; Arash Etemadi; Sanford M Dawsey; Linda M Liao; Christian C Abnet Journal: Am J Clin Nutr Date: 2017-08-02 Impact factor: 7.045